Mureva Phototherapy and Siemens Healthineers Announce U.S. Co-Marketing Agreement to Expand Access to the First FDA-Authorized Device for Radiation-Induced Oral Mucositis

PartnershipMurevaPositive

AI Analysis

Summary

Mureva Phototherapy and Siemens Healthineers announced a U.S. co-marketing agreement to expand access to Mureva, the first FDA-authorized intraoral device for radiation-induced oral mucositis. The collaboration aims to provide radiation oncology teams with practical delivery solutions.

Outcome Details

U.S. co-marketing agreement announced to expand access to FDA-authorized device

Importance:5/10

Sentiment:

0.60

PartnershipFDA-authorizedMedical deviceRadiation oncologyCo-marketing

Related Companies

$DFPH $TRAX

Read the original article

Published by PR Newswire Biotech on September 26, 2026 8:35 PM

Read Original